A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity

Successful cancer immune therapy correlates with a T cell-inflamed tumour microenvironment. Authors show here that co-administration of a self-adjuvanting protein vaccine and an antigen-expressing oncolytic virus in an optimised regimen strongly enhances T cell immunogenicity and may turn non-inflam...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Krishna Das, Elodie Belnoue, Matteo Rossi, Tamara Hofer, Sarah Danklmaier, Tobias Nolden, Liesa-Marie Schreiber, Katharina Angerer, Janine Kimpel, Sandra Hoegler, Bart Spiesschaert, Lukas Kenner, Dorothee von Laer, Knut Elbers, Madiha Derouazi, Guido Wollmann
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/6a4885a11bbe41c6aef5c595a4d1525a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6a4885a11bbe41c6aef5c595a4d1525a
record_format dspace
spelling oai:doaj.org-article:6a4885a11bbe41c6aef5c595a4d1525a2021-12-02T19:10:37ZA modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity10.1038/s41467-021-25506-62041-1723https://doaj.org/article/6a4885a11bbe41c6aef5c595a4d1525a2021-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25506-6https://doaj.org/toc/2041-1723Successful cancer immune therapy correlates with a T cell-inflamed tumour microenvironment. Authors show here that co-administration of a self-adjuvanting protein vaccine and an antigen-expressing oncolytic virus in an optimised regimen strongly enhances T cell immunogenicity and may turn non-inflamed tumours proinflammatory and less resistant to checkpoint blockade therapy.Krishna DasElodie BelnoueMatteo RossiTamara HoferSarah DanklmaierTobias NoldenLiesa-Marie SchreiberKatharina AngererJanine KimpelSandra HoeglerBart SpiesschaertLukas KennerDorothee von LaerKnut ElbersMadiha DerouaziGuido WollmannNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Krishna Das
Elodie Belnoue
Matteo Rossi
Tamara Hofer
Sarah Danklmaier
Tobias Nolden
Liesa-Marie Schreiber
Katharina Angerer
Janine Kimpel
Sandra Hoegler
Bart Spiesschaert
Lukas Kenner
Dorothee von Laer
Knut Elbers
Madiha Derouazi
Guido Wollmann
A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity
description Successful cancer immune therapy correlates with a T cell-inflamed tumour microenvironment. Authors show here that co-administration of a self-adjuvanting protein vaccine and an antigen-expressing oncolytic virus in an optimised regimen strongly enhances T cell immunogenicity and may turn non-inflamed tumours proinflammatory and less resistant to checkpoint blockade therapy.
format article
author Krishna Das
Elodie Belnoue
Matteo Rossi
Tamara Hofer
Sarah Danklmaier
Tobias Nolden
Liesa-Marie Schreiber
Katharina Angerer
Janine Kimpel
Sandra Hoegler
Bart Spiesschaert
Lukas Kenner
Dorothee von Laer
Knut Elbers
Madiha Derouazi
Guido Wollmann
author_facet Krishna Das
Elodie Belnoue
Matteo Rossi
Tamara Hofer
Sarah Danklmaier
Tobias Nolden
Liesa-Marie Schreiber
Katharina Angerer
Janine Kimpel
Sandra Hoegler
Bart Spiesschaert
Lukas Kenner
Dorothee von Laer
Knut Elbers
Madiha Derouazi
Guido Wollmann
author_sort Krishna Das
title A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity
title_short A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity
title_full A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity
title_fullStr A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity
title_full_unstemmed A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity
title_sort modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/6a4885a11bbe41c6aef5c595a4d1525a
work_keys_str_mv AT krishnadas amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT elodiebelnoue amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT matteorossi amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT tamarahofer amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT sarahdanklmaier amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT tobiasnolden amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT liesamarieschreiber amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT katharinaangerer amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT janinekimpel amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT sandrahoegler amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT bartspiesschaert amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT lukaskenner amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT dorotheevonlaer amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT knutelbers amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT madihaderouazi amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT guidowollmann amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT krishnadas modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT elodiebelnoue modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT matteorossi modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT tamarahofer modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT sarahdanklmaier modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT tobiasnolden modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT liesamarieschreiber modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT katharinaangerer modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT janinekimpel modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT sandrahoegler modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT bartspiesschaert modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT lukaskenner modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT dorotheevonlaer modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT knutelbers modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT madihaderouazi modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
AT guidowollmann modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity
_version_ 1718377091567714304